Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion type Assertion NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_head.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion description "[BCR-ABL mutations result in clinical resistance to ABL tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_provenance.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion evidence source_evidence_literature NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_provenance.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion SIO_000772 24062017 NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_provenance.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion wasDerivedFrom befree-20140225 NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_provenance.
- NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_assertion wasGeneratedBy ECO_0000203 NP754068.RAF3nRWhNiVU4vvVfRfZIYYDEeNNUsBgQgX78YWIJsF5c130_provenance.